Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,660
Total Claims
$589K
Drug Cost
329
Beneficiaries
$1,790
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-17%
Opioid rate vs peers
1.9% vs 2.2% avg
+27%
Cost per patient vs peers
$1,790 vs $1,411 avg
+172%
Brand preference vs peers
29.0% vs 10.6% avg
Opioid Prescribing
1.9%
Opioid Rate
161
Opioid Claims
$3,079
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,483 claims · $404K
Generic: 6,090 claims · $181K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 662 | $102K |
| Dextromethorphan Hbr/Quinidine | 123 | $71K |
| Rivaroxaban | 224 | $31K |
| Pimavanserin Tartrate | 13 | $29K |
| Insulin Glargine,hum.Rec.Anlog | 54 | $18K |
| Insulin Glargine,hum.Rec.Anlog | 36 | $15K |
| Rifaximin | 12 | $15K |
| Levothyroxine Sodium | 895 | $11K |
| Sevelamer Carbonate | 33 | $9,599 |
| Divalproex Sodium | 105 | $6,786 |
| Diltiazem Hcl | 101 | $6,672 |
| Sacubitril/Valsartan | 39 | $6,496 |
| Fluticasone/Umeclidin/Vilanter | 16 | $6,172 |
| Insulin Regular, Human | 38 | $5,678 |
| Ursodiol | 15 | $4,600 |
Prescribing Profile
Patient Profile
78
Avg Age
70%
Female
2.65
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About